Joanna Schaenman MD PhD

This is such a wonderful reference for anyone interested in transplant ID! #TID #IDSky @IDWeekmtg @TxID_Fellows #MedEd

Ten years ago, I published Grit. In those pages, I wrote down everything I’d discovered about world-class achievers and how passion and perseverance set them apart. Since then I’ve been studying the situations that make world-class achievement possible. My research shows that the situation shapes you—but you have the power to shape it first. How? 1. Set up your personal space. 2. Pick your peers. 3. Attract mentors. 4. Choose your culture. Getting situated means finding the people and places that bring out your best. Grit is great, but to realize your potential, you also need to get situated. Pre-order Situated. Out September 1st. angeladuckworth.com/situated

Fellows, residents and medical students: Present your cases at #IDWeek2026! All cases accepted for oral presentation will receive an $800 travel award (no additional application required). Learn more and submit by April 30: idweek.org/Cases/

Today on #JHLTThePodcast, we're joined by #TxID expert Cam Wolfe to talk about the current state of #HIV infection in solid organ #transplantation worldwide.

🚨 Editor’s Choice 🚨 "Cellular and humoral immunogenicity of respiratory syncytial virus vaccination in solid organ transplant recipients," by Bronder et al doi.org/10.1016/j.ajt.… #OpenAccess #Immunogenicity #RSV #SolidOrganTransplantation

@AliNsairMD @datsunian @KingJames @UCLAHealth @Lakers @DOM_UCLA @dgsomucla @UCLAAthletics @gcfmd @JeffHsuMD Wow! Thank you @KingJames for visiting @UCLAHealth and bringing some joy to our cardiac patients!

When you do CCU rounds with the 👑 @KingJames who spends time visiting with your cardiology patients! Grateful patients, family and staff @UCLAHealth @Lakers x.com/i/status/20318…

@ABsteward Thanks for sharing this very interesting meta analysis on letermovir prophylaxis in SOT- I feel like valganciclovir may be joining the vancomycin , poly B, and aminoglycosides club , as a medication that we will be glad not to have to use routinely

Beyond valganciclovir! 🆕⚡🟢Meta-analysis of letermovir’s safety and efficacy in cytomegalovirus prophylaxis after solid organ transplantation 6 studies: 1 RCT + 5 retrospective or matched cohort studies N= 1,413 recipients (526 LTV; 887 VGC) LTV significantly reduced CMV DNAaemia during prophylaxis (RR = 0.33, 95% CI 0.18–0.59; I² = 0%), with comparable CMV disease incidence (RR = 0.87, 95% CI 0.41–1.88). Post-prophylaxis CMV infection, graft rejection, graft loss, and mortality were similar between groups. LTV showed numerically lower rates of neutropenia, leukopenia, and G-CSF use, reflecting improved haematologic safety, although between-study heterogeneity was substantial #IDXposts link.springer.com/article/10.118…

Get out the vote! Voting for IDCOP Exec Committee has begun. Check your email for link.

This is important study! I think it's time to raise awareness about the importance of monitoring for low immunoglobulin levels and repleting patients to prevent infections- this approach may have additional benefits in preventing alloimmunity as well @AST_IDCOP @AST_KPCOP

@AST_IDCOP Sorry to have missed the @AST_IDCOP Town Hall! Will the slides or content be shared with the #TID community? 😀

🚨🙀T minus 20 minutes until the IDCOP Town Hall. See you there??! (Check the Hub for zoom link) #TxID

@Yjjli1 @TxID_Fellows @AST_IDCOP @IDSAInfo @InfectDisNews Please send me a DM - thanks for your interest!

@jschaenman @TxID_Fellows @AST_IDCOP @IDSAInfo @InfectDisNews Hi, I submitted my application. I'd like to know when the interview starts

We are still accepting applications for our #TID fellowship/advanced training year at UCLA for 2026-27 ☀️ 🌴 - please reach out w any questions about this opportunity! recruit.apo.ucla.edu/JPF10380 #MedEd #ID @TxID_Fellows @AST_IDCOP @IDSAInfo @InfectDisNews

Excited to have this published just now, with thanks to my collaborators!! ⁦@StephaniePouch⁩ ⁦@HumarAtul⁩

Curious about what’s happening within the IDCOP? Join us Friday, March 6, from 2–3 PM ET for our Town Hall — your chance to hear directly from the Executive Committee about ongoing initiatives, upcoming projects, and ways to get involved. Login to IDCOP Hub for more details!

@TransplantJrnl Thank you for reposting this! These BK guidelines represented a unique international partnership of #TID , nephrology, and laboratory experts led by @KottonNelson @HansHHirsch1 and other leaders in the field @AST_IDCOP @AST_KPCOP

#TBT to this week's featured top downloaded paper from 2025: The Second International Consensus Guidelines on the Management of BK Polyomavirus in Kidney Transplantation #Transplantation #Med tinyurl.com/24nuxvpf

@amjtransplant This is an important study on anti HLA antibody appearance after blood transfusion in Kidney Transplant recipients. Interesting finding that HLA class I antibodies were much more common than HLA class II @AST_KPCOP

🚨 Editor’s Choice 🚨 "Human leukocyte antigen sensitization from red cell transfusions: Rate and risk factors in renal and nonrenal patients requiring transfusion," by McComish et al authors.elsevier.com/sd/article/S16… #openaccess #transplantation #kidneytransplantation

@ABsteward This is a great review on managing drug levels with antifungal therapies, so helpful to have all of these different medications together in one article!

🆕🔥🔴 Review article Precision dosing of systemic antifungals in adults: therapeutic drug monitoring, empiric dose optimization and barriers to implementation #IDXposts #TDM academic.oup.com/jac/article-ab…

@MichaelGIsonMD @HannahNamMD @NM_IDSteward Thanks for sharing this important work on healthcare associated viral infections. I think this also has important implications for masking rules for healthcare workers taking care of immunocompromised patients @AST_IDCOP

Not surprisingly, most adults healthcare-associated respiratory virus infections are immunocompromised and they account for the sickest patients. A key signal to better protect our most vulnerable patients. @HannahNamMD @NM_IDSteward onlinelibrary.wiley.com/doi/10.1111/ti…

Join us this week for a webinar on 𝐍𝐚𝐯𝐢𝐠𝐚𝐭𝐢𝐧𝐠 𝐁𝐢𝐨𝐥𝐨𝐠𝐢𝐜 𝐓𝐡𝐞𝐫𝐚𝐩𝐢𝐞𝐬 𝐟𝐨𝐫 𝐍𝐨𝐧-𝐓𝐫𝐚𝐧𝐬𝐩𝐥𝐚𝐧𝐭 𝐈𝐧𝐝𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬 𝐢𝐧 𝐒𝐨𝐥𝐢𝐝 𝐎𝐫𝐠𝐚𝐧 𝐓𝐫𝐚𝐧𝐬𝐩𝐥𝐚𝐧𝐭 𝐑𝐞𝐜𝐢𝐩𝐢𝐞𝐧𝐭𝐬. bit.ly/3ZsKJfu

@sebpoule @IdVilchez @BradSpellberg @JulianVentres @DrToddLee @ABsteward @dralicehan I think another issue in the C diff discussion is whether the patient is immunosuppressed or has other risk factors for progression to severe disease. I do support the 2 tier test, but also think treating a high risk patient with PCR *+/ Eia- and is very symptomatic makes sense

I agree with you (and Brad) My 2 cents : -There are «bad» I.D. docs out there. (as in any other specialties) -For many (most?) doctors, it's hard to ignore a «positive» test (PCR + EIA -) Bottomline, C.diff PCR+ / EIA - is tricky p.s. I'm still a big supporter of 2-tier C.diff test

#IDTWITTER I think someone already talked about this but I am not sure if I got it right, so just to double check, for a first time C diff colitis, are we using a long taper anyway? 4wk? 6 wk? @DrToddLee @ABsteward @BradSpellberg @dralicehan

Love this! A+++ 💀